Fabtech Technologies’ IPO will open on September 29, 2025, and close on October 1, 2025. It is a Book Built Issue through which the company aims to raise ₹230.35 crores, consisting entirely of a fresh issue of the same amount, along with an offer for sale of equity shares with a face value of ₹10 each.

The price band has been set at ₹181 to ₹191 per share. The quota allocation is 35% for retail investors, 50% for QIBs, and 15% for HNIs. Listing is scheduled on BSE and NSE on October 7, 2025, and the IPO allotment date is October 3, 2025.

Financially, the company posted a revenue of ₹335.94 crores in 2025, up from ₹230.39 crores in 2024, and a profit of ₹46.45 crores in 2025 compared to ₹27.22 crores in 2024. Considering these numbers, long-term investment in this IPO appears favorable.

About Fabtech Technologies IPO

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.

The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customized engineering solutions.

It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards.

Services:

• Start-to-Finish: The company helps people in bio-pharma manufacturing life cycle from setting direction right through to taking your products to market.
• Clean Water Solutions: The company offer a comprehensive range of equipment for purified water and pure steam generation and distribution as well as water for injections with flow rates ranging from 500 LPH to 50,000 LPH.
• Clean Air Solutions: The company supported life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative solutions for clean air applications that drive their growth and progress.

As of July 31, 2025, the company had 185 permanent employees.